Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
25 and 50 mg diclofenac K film coated immediate release tablets More
Fentanyl patch for the management of severe pain in patients who require continuous opioid analgesia. More
Apitoxin is a new biological drug for pain & inflammation and arthritis, approved by the Korean FDA on May 3, 2003 after 14 years of preclinical, animal, and phase I, II & III clinical studies More
25mg dosage strenght for the OTC market in film coated tablets More
The First Line of Therapy in Severe Migraine Attacks More
12,5 mg diclofenac K film coated immediate release tablets (OTC) More
The first pure, immediate release (Tmax in 13,68 min), completely palatable and free from aftertaste diclofenac potassium formulation in drops at 5% available on the market More
Opioid receptor blocker which reduces desire for opioids and alcohol, use in psychiatry, neurology and addition medicine. More
Kappa opioid receptor agonist/ mü antagonist providing analgesia, while preventing respiratory depression More
Opioid receptor antagonist reducing opioid induced respiratory depression More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2006 - 1068 pages - $2,495
Oct 2010 - 53 pages - $1,000
Sep 2011 - 97 pages - $3,500
Feb 2011 - 75 pages - $1,000
Jan 2010 - $75
Aug 2010 - 76 pages - $1,500
Nov 2011 - 61 pages - $3,800
Jun 2010 - 67 pages - $1,000
Mar 2011 - 107 pages - $3,500
Jan 2010 - $75
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Age-related disorders (other)
- Amyotrophic lateral sclerosis
- CNS (other)
- Neurodegenerative disorders
- Neurological
- Pain
- Psychiatric
- Subarachnoid hemorrhage
- Traumatic brain injury
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us